Related Experiment Video
Updated: Jan 16, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.4K
Heterogeneity in breast cancer
1Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA. Kornelia_Polyak@dfci.harvard.edu
The Journal of Clinical Investigation
|October 4, 2011
Summary
Breast cancer exhibits significant heterogeneity, impacting disease progression and treatment resistance. Understanding this diversity is key to developing effective, personalized therapies for patients.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Breast cancer is a complex disease characterized by significant heterogeneity within and between tumors, influencing patient outcomes.
- Tumor diversity and the tumor microenvironment are critical determinants of disease progression and therapeutic resistance.
- Technological advancements like whole-genome sequencing enable deeper analysis of tumor characteristics.
Discussion:
- Review of recent advances in understanding breast tumor heterogeneity.
- Exploration of therapies tailored to specific tumor characteristics.
- Discussion of challenges in translating knowledge of heterogeneity into clinical practice.
Key Insights:
- Tumor heterogeneity is a critical factor in breast cancer progression and therapeutic resistance.
- Advanced sequencing and screening technologies provide unprecedented insights into tumor diversity.
- Bridging the gap between research and clinical application requires addressing tumor evolution.
Outlook:
- Future strategies for assessing and treating heterogeneous breast tumors.
- Developing personalized treatment approaches based on a comprehensive understanding of tumor biology.
- Harnessing knowledge of heterogeneity to improve patient outcomes and overcome therapeutic challenges.
More Related Videos
Related Concept Videos
02:18Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
02:21Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K